Verve Therapeutics is a biotechnology company created with a singular focus to protect the world from heart disease. Verve is committed to discovering and developing therapies that safely edit the genome of adults to confer lifelong protection from coronary artery disease, the most common form of heart disease and the leading cause of death worldwide. Headquartered in Cambridge, Massachusetts, Verve was founded by world-leading experts in cardiovascular medicine and gene editing and is backed by a top-tier syndicate of investors, including GV (formerly Google Ventures), ARCH Venture Partners, F-Prime Capital Partners, and Biomatics Capital.
We are seeking a self-motivated and technically competent Research Associate focused on developing molecular therapies to address genetic risk factors for cardiovascular disease. The candidate will help advance our early research efforts to preclinical and clinical development using cellular and animal models. The candidate should have a proven track record of scientific productivity. He/she will have the opportunity to translate basic research findings into novel therapeutic strategies that may eventually support clinical drug development. Although experience related to cardiovascular disease is desirable, candidates with relevant experience in next generation sequencing (NGS) and cell culture are encouraged to apply.
Verve Therapeutics is proud to be an equal opportunity workplace and is an affirmative action employer. We are committed to equal employment opportunity regardless of race, color, ancestry, religion, sex, national origin, sexual orientation, age, citizenship, marital status, disability, gender identity or Veteran status. If you have a disability or special need that requires accommodation, please let us know.
Verve Therapeutics does not